| Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies JMGR de Morales, L Puig, E Daudén, JD Cañete, JL Pablos, AO Martín, ... Autoimmunity reviews 19 (1), 102429, 2020 | 264 | 2020 |
| Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) initiative AD Dick, JT Rosenbaum, HA Al-Dhibi, R Belfort Jr, AP Brézin, SP Chee, ... Ophthalmology 125 (5), 757-773, 2018 | 229 | 2018 |
| Safety and efficacy of adalimumab in patients with noninfectious uveitis in an ongoing open-label study: VISUAL III EB Suhler, A Adán, AP Brézin, E Fortin, H Goto, GJ Jaffe, T Kaburaki, ... Ophthalmology 125 (7), 1075-1087, 2018 | 160 | 2018 |
| Anti–interleukin‐6 receptor tocilizumab for severe juvenile idiopathic arthritis–associated uveitis refractory to anti–tumor necrosis factor therapy: a multicenter study of … V Calvo‐Río, M Santos‐Gómez, I Calvo, MI González‐Fernández, ... Arthritis & Rheumatology 69 (3), 668-675, 2017 | 152 | 2017 |
| Anti-TNF-α therapy in patients with refractory uveitis due to Behçet’s disease: a 1-year follow-up study of 124 patients V Calvo-Río, R Blanco, E Beltrán, J Sánchez-Bursón, M Mesquida, ... Rheumatology 53 (12), 2223-2231, 2014 | 141 | 2014 |
| Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization V Llorenç, M Mesquida, M Sainz de la Maza, J Keller, B Molins, ... Acta Ophthalmologica 93 (6), 561-567, 2015 | 138 | 2015 |
| Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency J Zarranz-Ventura, E Carreño, RL Johnston, Q Mohammed, AH Ross, ... American journal of ophthalmology 158 (6), 1136-1145. e5, 2014 | 137 | 2014 |
| Interleukin-6 blockade in ocular inflammatory diseases M Mesquida, A Leszczynska, V Llorenç, A Adán Clinical & Experimental Immunology 176 (3), 301-309, 2014 | 129 | 2014 |
| Tocilizumab treatment for refractory uveitis-related cystoid macular edema A Adán, M Mesquida, V Llorenç, G Espinosa, B Molins, MV Hernández, ... Graefe's Archive for Clinical and Experimental Ophthalmology 251, 2627-2632, 2013 | 128 | 2013 |
| Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus R Bou, A Adán, F Borrás, B Bravo, I Calvo, J De Inocencio, J Díaz, ... Rheumatology international 35, 777-785, 2015 | 126 | 2015 |
| Adalimumab for the treatment of Behçet’s disease: experience in 19 patients D Perra, MA Alba, JL Callejas, M Mesquida, R Ríos-Fernández, A Adan, ... Rheumatology 51 (10), 1825-1831, 2012 | 118 | 2012 |
| Anti-IL6-receptor tocilizumab in refractory and noninfectious uveitic cystoid macular edema: multicenter study of 25 patients N Vegas-Revenga, V Calvo-Río, M Mesquida, A Adán, MV Hernández, ... American Journal of Ophthalmology 200, 85-94, 2019 | 116 | 2019 |
| Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema M Mesquida, B Molins, V Llorenç, MS de la Maza, A Adán Ophthalmology 121 (12), 2380-2386, 2014 | 116 | 2014 |
| Evidence for tocilizumab as a treatment option in refractory uveitis associated with juvenile idiopathic arthritis C Tappeiner, M Mesquida, A Adán, J Anton, AV Ramanan, E Carreno, ... The Journal of rheumatology 43 (12), 2183-2188, 2016 | 113 | 2016 |
| Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients A Adán, L Pelegrín, A Rey, V Llorenç, M Mesquida, B Molins, J Ríos, ... Retina 33 (7), 1435-1440, 2013 | 104 | 2013 |
| Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients L Riancho-Zarrabeitia, V Calvo-Río, R Blanco, M Mesquida, AM Adan, ... Seminars in arthritis and rheumatism 45 (3), 361-368, 2015 | 96 | 2015 |
| Ocular syphilis—back again: understanding recent increases in the incidence of ocular syphilitic disease A Fonollosa, J Giralt, L Pelegrín, B Sánchez-Dalmau, A Segura, ... Ocular immunology and inflammation 17 (3), 207-212, 2009 | 95 | 2009 |
| Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization AM Mansour, JF Arevalo, F Ziemssen, A Mehio-Sibai, F Mackensen, ... American journal of ophthalmology 148 (2), 310-316. e2, 2009 | 93 | 2009 |
| Behçet disease-associated uveitis successfully treated with golimumab M Mesquida, M Victoria Hernández, V Llorenç, L Pelegrín, G Espinosa, ... Ocular Immunology and Inflammation 21 (2), 160-162, 2013 | 92 | 2013 |
| Comparative study of infliximab versus adalimumab in refractory uveitis due to Behçet's disease: national multicenter study of 177 cases B Atienza‐Mateo, JL Martín‐Varillas, V Calvo‐Río, R Demetrio‐Pablo, ... Arthritis & Rheumatology 71 (12), 2081-2089, 2019 | 87 | 2019 |
